Self-ventilating patients

Aerogen delivers aerosol medication to your self-ventilating patients requiring symptom control for respiratory exacerbations1,2

Aerosol drug delivery

Aerogen facilitates effective medication delivery during self-ventilation1–4

In studies, bronchodilator administration via the Aerogen Ultra was associated with:

  • 6x more medication delivered to the lungs during self ventilation versus a jet nebuliser†3
  • Significantly less medication left in the cup versus other nebulisers‡4 

Study performed in healthy subjects; between-group difference: 34.1% vs 5.2%; p<0.001
In-vitro/ex vivo models

Discover more

Self-ventilating, effective medication delivery

Ease of use

Aerogen simplifies the workflow

  • Aerogen Solo is intended for the aerosolisation of any  physician-prescribed solutions for inhalation5
  • One system used throughout a patients' respiratory journey (IMV, NIV, HF, self-ventilating),5 supporting continuity of care
  • Virtually silent drug delivery,5 keeping a calm environment for your patients
  • No added flow required5

Speak to a clinical specialist

Self-ventilating, Aerogen simplifies the workflow

Effectiveness

Aerogen improves patient care in response to aerosolised medication1,2

In studies, when compared with jet nebulisers, bronchodilator administration via Aerogen Ultra was associated with:

In children with a moderate-to-severe asthma exacerbation:
  • Significantly fewer treatments and significantly less time required to achieve symptom control†1

Across all patients in an emergency department :

  • 30% relative reduction in hospital admission rates2
  • 85% of patients achieving symptom control with one 2.5 mg salbutamol dose2
  • 37-minute reduction in ED median length of stay2

Defined as achieving a mild asthma score following an asthma exacerbation

Read the evidence

Self-ventilating, Aerogen improves patient care

Guidelines

Recommended by clinical and scientific societies around the world 

Clinical and scientific societies around the world recommend the use of closed-circuit nebulisers for the management of patients with COVID-19 requiring aerosol drug delivery:

  • GOLD: Science Committee Report 20236
  • AARC: Guidance 20207
  • ISAM: Interim Guidance 20208
  • Spanish Scientific Societies: Expert Clinical Consensus 20209
  • Chinese Thoracic Society: Respiratory Care Committee 202010
  • Indian Society of Critical Care Medicine: Position Statement 202011
  • Indian Chest Society: Guidance 202012

Globally renowned

Aerogen technology has been in use for over 20 years, in more than 75 countries globally and  is associated with over 200 clinical papers and publications.13 Aerogen is the partner of choice for the world's leading ventilator companies for aerosol drug delivery.

Self-ventilating, enquiries

Enquiries

The Aerogen team and our representatives are available globally to answer your questions, provide an online demonstration and place orders

How can we help

Self-ventilating, Non-invasive ventilation

Non-invasive ventilation

Discover more

Self-ventilating, High-flow nasal cannula

High-flow

Discover more

Self-ventilating, discover more

Self-ventilating

Discover more

 

  1. Moody GB, Luckett PM, Shockley CM, et al. Respir Care 2020;65(10):1451–1463.
  2. Dunne RB, Shortt S. Am J Emerg Med. 2018;36(4):641-646.
  3. Dugernier J, Hesse M, Vanbever R, et al. Pharm Res. 2017;34(2):290-30.
  4. Lin H-L, Fang T–P, Cho H-S, et al. Pulm Pharmacol Ther. 2018;48:225-231.
  5. Aerogen Solo Instruction Manual
  6. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: 2023 report. Available at: https://goldcopd.org/2023-gold-report-2/ (accessed 06 December 2022).
  7. American Association for Respiratory Care SARS CoV-2 Guidance Document. https://www.aarc.org/wp-content/
  8. uploads/2020/03/guidance-document-SARS-COVID19.pdf (accessed 11 Nov 2022). 
  9.  Fink JB, Ehrmann S, Li J, et al. J Aerosol Med Pulm Drug Deliv. 2020;33(6):300-304.
  10. Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, et al. Med Intensiva (Engl Ed). 2020;44(7):429-438.
  11. Respiratory care committee of Chinese Thoracic Society. Zhonghua Jie He He Hu Xi Za Zhi. 2020;17(0):E020.
  12. Kumar S, Mehta S, Sarangdhar N, et al. Expert Rev Respir Med. 2021;15(4):519-535.
  13. Swarnakar R, Gupta NM, Halder I, et al. Lung India. 2021;38(Supplement):S86-S91.
  14. Aerogen Data on File

GL1226A09-22